Although the 17 lectures delivered at this year‘s Medical Technology Congress in Berlin, Germany, focused on topics ranging from experimental and clinical research to routine daily diagnostic methods, the pervading interest was in the improvement, development and distribution of non-invasive imaging devices and corresponding software.
How low? During the GE Healthcare Lunch Symposium of GE Healthcare at this year’s ECR in Vienna, Michael Maher, Professor of Radiology at the University College, Cork, provided an answer: 1.2 millisievert – at least for abdominal CT scans in patients with Crohn’s disease.
United Kingdom – A call has been made for tighter regulatory controls to ensure the safety regulation of medical devices, following joint investigations carried out by the British Medical Journal and the Channel 4 TV programme Dispatches, which were televised and published online at BMJ.com this May.
PredictAD is an EU-funded research project that develops objective and efficient methods for enabling earlier diagnosis of Alzheimer's disease. Diagnosis requires a holistic view of the patient combining information from several sources, such as, clinical tests, imaging and blood samples.
Dr Bill Svensson believes that elastography has the potential to improve diagnosis of breast cancer, reduce the number of false positives in the detection of the condition and also lead to fewer biopsies performed as accuracy of imaging improves further. This June he highlighted the potential of elastography and the developments in the imaging modality at two sessions at the United Kingdom…
Breast cancer is the most common form of cancer in women. Evaluation of the axillary lymph nodes is essential to insure complete cancer removal. Fluorescence imaging instead of radioisotopes is an innovative method for sentinel lymph node detection.
Every medical congress is an opportunity for the manufacturers to showcase their products. This year’s congress of the German Röntgen Society was no exception -- and one innovation particularly caught the attention of our European Hospital team: positron emission mammography, PEM for short.
Morbid obesity is a chronic, lifelong, multifactorial, constitutional disease with negative medical, psychological, physical, social and economic side-effects. Obesity-related secondary diseases are Type 2 diabetes mellitus (T2DM), cardiovascular diseases such as hypertension or sleep apnoea. Report: Holger Zorn
Given the increase in overweight or obese populations (estimated at around 50% in Europe alone), hospital equipment that supports patients must be tried, tested and proved to be robust indeed. Like many hospital equipment manufacturers, the Tuttlingen-based firm Berchtold is well aware of this growing concern, already providing components and accessories for obesity surgery.
Although powerful, new, targeted treatments are regularly introduced to cancer clinics, choices for the first-line treatment of invasive breast cancer normally lie between preventive surgery and chemotherapy. A recent American study used genomic prediction combining multiple signatures to determine outcomes to standard chemotherapy.
Initially meant to bridge the gap before a heart transplant is performed, today ventricular assist devices (VADs) are increasingly considered ‘a lasting therapy option’, according to Professor Heinrich Schima, Head of the Centre for Medical Physics and Biomedical Technology at the Medical University of Vienna.
One year ago interventional cardiologists raised champagne glasses to celebrate the first publication of clinical evidence showing that transcatheter valve implants (TAVI) is safe and effective. In May at EuroPCR 2011, cardiologists raised magnifying glasses to look closer at further clinical results. John Brosky reports from Paris
The clinical informatics firm ICNet International Ltd, which develops case management and surveillance software, has produced a software package using the SSI (Surgical Site infection surveillance) Monitor to combine information about patient movements in a hospital with data held by the laboratory and theatre systems -- and to alert staff if a patient is either infected or at risk of contracting…
Facing the fundamental changes that laboratory medicine is undergoing, in early June Roche Diagnostics Deutschland GmbH invited 50 high-profile speakers to a six-day symposium to discuss current research, economic and diagnostic issues in lab medicine with a professional audience. Report: Karoline Laarmann
Hitachi Medical Corporation is delighted to announce that its HI VISION Avius ultrasound platform has been selected as a recipient of the iF product design award 2011 and is proud to now carry the iF design quality label.
The European Society of Cardiology (ESC) is calling for a single, co-ordinated European system to oversee the evaluation and approval of medical devices. The call is being made in a paper published online in the European Heart Journal reporting on a conference held by the ESC in January 2011 looking to increase the input of medical experts in developing medical device policy.
Edwards Lifesciences Corporation, a global leader in the science of heart valves and hemodynamic monitoring, announced that interim data from a multi-center European prospective study of the investigational EDWARDS INTUITY Valve System showed promising results for patients undergoing surgical aortic valve replacement (AVR).
IBA Group, a leader in advanced cancer diagnosis and therapy technologies and Royal Philips Electronics, announced they have entered into an agreement to create state of the art patient-centric proton therapy centers.
Shimadzu, world-wide manufacturer of diagnostic imaging equipment, has introduced the first wireless flat-panel detector (FPD) for its mobile, fully digital X-ray system MobileDaRt Evolution. This new CXDI-70C detector generation is the next evolutionary step for mobile X-ray applications.
Carestream Health is one of the first healthcare IT providers to conduct pre-launch testing of the new Intel® Xeon® processor E7 product family in its industry-leading medical image management, archiving and distribution systems. These tests indicate the new high-performance processors can equip Carestream Health’s PACS and SuperPACS™ Architecture to deliver responsive access to a larger…
The lives of people who find communication difficult are to be dramatically improved following a report published by Devices for Dignity (D4D), into Voice Output Communications Aids (VOCAs). The free to access report, whose development was led by Barnsley Hospital and NHS Sheffield as part of a D4D consortium, is designed to improve the development of new technologies and stimulate further…
CardioFocus, Inc., developer of the Endoscopic Ablation System for the transcatheter treatment of Atrial Fibrillation (AF), convened international leaders in electrophysiology to discuss the advantages of direct optical visualization to guide catheter ablation for the treatment of paroxysmal AF.
Scientists of the Charité – Universitätsmedizin Berlin and the Max-Delbrück-Center for Molecular Medicine (MDC) Berlin-Buch have developed a highly efficient approach for imaging the beating human heart. The images produced in one of the world's most powerful MRI systems whose power is equivalent to 150.000 times the earth’s magnetic field are of a much higher detail than cardiac images…
A little over three decades after the world's first human heart transplant (HT), Carmat’s life-size artificial heart, a mix of animal tissue, titanium and missile technology that perfectly replicate a human heart, might save the lives of thousands.
This March, Heinz-Dieter Hilgers arrived for his once-monthly check-up at Ruhrlandklinik in Essen. Last June, his situation was far less relaxed. Suffering chronic obstructive pulmonary disease (COPD) for almost two years, he had been listed for a lung transplant since April 2009. During his wait for an organ, his illness increased.